Children remain more vulnerable to influenza despite protective antibody levels
Twice-weekly household testing across three influenza seasons shows why conventional antibody measures tell only part of the story…
Spring programme offers respiratory illness jabs
People more vulnerable to respiratory illnesses have been encouraged to take up the offer of a vaccination in…
Major UK clinical trial finds surfactant therapy ineffective for severe bronchiolitis
A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers…
RSV and COVID-19 trigger different immune responses in infants
Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker compared to those infected with SARS-CoV-2,…
Survey shows growing public familiarity with RSV vaccines and antibody injections
Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing the…
FDA opens safety review of injectable drugs for RSV in kids
WASHINGTON (AP) — Food and Drug Administration officials have opened a safety review of two injectable drugs used…
Hospital’s campaign amid ‘severe flu season’
A hospital has called for people to take precautions to ease the burden on NHS services as the…
Preparing for the respiratory virus season: A guide for families
As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial…
Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season
Real-world data confirm that nirsevimab provides powerful protection for infants, reducing RSV hospital stays and easing the strain…